Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.

[1]  B. Massie,et al.  Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study , 1983, Circulation.

[2]  B. Massie,et al.  Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. , 1982, Circulation.

[3]  R. Gorlin,et al.  Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. , 1982, The New England journal of medicine.

[4]  M. Packer,et al.  Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure. , 1982, Progress in cardiovascular diseases.

[5]  R. Gorlin,et al.  Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy , 1981, Circulation.

[6]  E. Braunwald,et al.  Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. , 1981, The American journal of medicine.

[7]  J. Halperin,et al.  Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. , 1981, American heart journal.

[8]  B. Massie,et al.  Postural Hypotension and Tachycardia During Hydralazine‐Isosorbide Dinitrate Therapy for Chronic Heart Failure , 1981, Circulation.

[9]  B. Massie,et al.  Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.

[10]  E. Espiner,et al.  HAEMODYNAMIC, HORMONAL, AND ELECTROLYTE RESPONSES TO CAPTOPRIL IN RESISTANT HEART FAILURE , 1981, The Lancet.

[11]  BMassie,et al.  Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure. , 1981 .

[12]  D. Mason,et al.  Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. , 1981, American heart journal.

[13]  R. Gorlin,et al.  Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.

[14]  J. Cohn,et al.  Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure , 1980, Circulation.

[15]  N. Hollenberg,et al.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.

[16]  B. Brundage,et al.  Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. , 1980, Annals of internal medicine.

[17]  B. Brundage,et al.  Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor , 1980, Circulation.

[18]  R. Gorlin,et al.  Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.

[19]  J. Cohn,et al.  Effect of Hydralazine on Renal Failure in Patients with Congestive Heart Failure , 1980, Circulation.

[20]  R. Tarazi,et al.  Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure. , 1979, The American journal of cardiology.

[21]  E. Sonnenblick,et al.  Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. , 1979, The New England journal of medicine.

[22]  B. Massie,et al.  Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. , 1977, The American journal of cardiology.

[23]  J. Cohn,et al.  Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.

[24]  Opie Lh.  Letter: Exercise, sport, and sudden death. , 1975 .

[25]  E. Braunwald,et al.  A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. , 1968, The Journal of clinical investigation.